Cargando…

Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism

BACKGROUND: Primary hyperparathyroidism is a rare disease characterized by excessive secretion of parathyroid hormone from parathyroid adenoma, hyperplasia, or malignancy. The clinical symptoms of the condition are those of hypercalcemia. Although the lesions are commonly located in the neck region,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitada, Masahiro, Yasuda, Shunsuke, Nana, Takahashi, Ishibashi, Kei, Hayashi, Satoshi, Okazaki, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825079/
https://www.ncbi.nlm.nih.gov/pubmed/27056365
http://dx.doi.org/10.1186/s13019-016-0461-8
_version_ 1782426163874889728
author Kitada, Masahiro
Yasuda, Shunsuke
Nana, Takahashi
Ishibashi, Kei
Hayashi, Satoshi
Okazaki, Satoru
author_facet Kitada, Masahiro
Yasuda, Shunsuke
Nana, Takahashi
Ishibashi, Kei
Hayashi, Satoshi
Okazaki, Satoru
author_sort Kitada, Masahiro
collection PubMed
description BACKGROUND: Primary hyperparathyroidism is a rare disease characterized by excessive secretion of parathyroid hormone from parathyroid adenoma, hyperplasia, or malignancy. The clinical symptoms of the condition are those of hypercalcemia. Although the lesions are commonly located in the neck region, in about 1–2 % of cases, the lesions are ectopically located within the mediastinum, where surgical excision using the cervical approach is difficult. The principal treatment of the condition is surgical excision of the lesion. However, some patients require additional surgery because of recurrence due to intraoperative dissemination. Therefore, safe and accurate excision is essential for the treatment. We reviewed the surgical treatment used at our institution for mediastinal parathyroid adenoma that caused primary hyperparathyroidism. METHOD: The subjects were four patients with primary hyperparathyroidism due to mediastinal parathyroid adenoma who underwent surgery at our institution within a period of 10 years, between January 2005 and December 2014. All of the patients were female, with a mean age of 64.5 years (range, 55–74 years). The examined variables included background factors, clinical condition, surgical method, and clinical outcome. RESULT: In all of the patients, primary hyperparathyroidism was detected with symptoms of hypercalcemia. Laboratory tests revealed a mean serum calcium level of 11.85 mg/dL (range, 11.2–13.2 mg/dL) and a mean parathyroid hormone (intact PTH) level of 304.8 pg/mL (range, 126–586 pg/mL), indicating elevated levels for all patients. Chest computed tomography (CT) revealed tumors with a mean diameter of 2.8 cm (range, 10–45 mm) in the anterior mediastinum in all of the patients. On 99mTC-methoxy isobutyl isonitrile (MIBI) scintigraphy, abnormal accumulation was observed in all of the patients. Regarding the surgical methods, median sternotomy was used for three cases and upper partial sternotomy was used for one case. The surgery was safely and accurately performed, without postoperative complications. After surgery, the serum calcium levels immediately returned to normal and the symptoms improved. CONCLUSION: We performed excision safely and accurately in all of the patients. In tumor identification, 99mTC-MIBI scintigraphy was useful. Accurate tumor identification and selection of the optimal surgical method are important for prevention of recurrence due to intraoperative dissemination.
format Online
Article
Text
id pubmed-4825079
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48250792016-04-09 Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism Kitada, Masahiro Yasuda, Shunsuke Nana, Takahashi Ishibashi, Kei Hayashi, Satoshi Okazaki, Satoru J Cardiothorac Surg Research Article BACKGROUND: Primary hyperparathyroidism is a rare disease characterized by excessive secretion of parathyroid hormone from parathyroid adenoma, hyperplasia, or malignancy. The clinical symptoms of the condition are those of hypercalcemia. Although the lesions are commonly located in the neck region, in about 1–2 % of cases, the lesions are ectopically located within the mediastinum, where surgical excision using the cervical approach is difficult. The principal treatment of the condition is surgical excision of the lesion. However, some patients require additional surgery because of recurrence due to intraoperative dissemination. Therefore, safe and accurate excision is essential for the treatment. We reviewed the surgical treatment used at our institution for mediastinal parathyroid adenoma that caused primary hyperparathyroidism. METHOD: The subjects were four patients with primary hyperparathyroidism due to mediastinal parathyroid adenoma who underwent surgery at our institution within a period of 10 years, between January 2005 and December 2014. All of the patients were female, with a mean age of 64.5 years (range, 55–74 years). The examined variables included background factors, clinical condition, surgical method, and clinical outcome. RESULT: In all of the patients, primary hyperparathyroidism was detected with symptoms of hypercalcemia. Laboratory tests revealed a mean serum calcium level of 11.85 mg/dL (range, 11.2–13.2 mg/dL) and a mean parathyroid hormone (intact PTH) level of 304.8 pg/mL (range, 126–586 pg/mL), indicating elevated levels for all patients. Chest computed tomography (CT) revealed tumors with a mean diameter of 2.8 cm (range, 10–45 mm) in the anterior mediastinum in all of the patients. On 99mTC-methoxy isobutyl isonitrile (MIBI) scintigraphy, abnormal accumulation was observed in all of the patients. Regarding the surgical methods, median sternotomy was used for three cases and upper partial sternotomy was used for one case. The surgery was safely and accurately performed, without postoperative complications. After surgery, the serum calcium levels immediately returned to normal and the symptoms improved. CONCLUSION: We performed excision safely and accurately in all of the patients. In tumor identification, 99mTC-MIBI scintigraphy was useful. Accurate tumor identification and selection of the optimal surgical method are important for prevention of recurrence due to intraoperative dissemination. BioMed Central 2016-04-07 /pmc/articles/PMC4825079/ /pubmed/27056365 http://dx.doi.org/10.1186/s13019-016-0461-8 Text en © Kitada et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kitada, Masahiro
Yasuda, Shunsuke
Nana, Takahashi
Ishibashi, Kei
Hayashi, Satoshi
Okazaki, Satoru
Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism
title Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism
title_full Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism
title_fullStr Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism
title_full_unstemmed Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism
title_short Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism
title_sort surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825079/
https://www.ncbi.nlm.nih.gov/pubmed/27056365
http://dx.doi.org/10.1186/s13019-016-0461-8
work_keys_str_mv AT kitadamasahiro surgicaltreatmentformediastinalparathyroidadenomacausingprimaryhyperparathyroidism
AT yasudashunsuke surgicaltreatmentformediastinalparathyroidadenomacausingprimaryhyperparathyroidism
AT nanatakahashi surgicaltreatmentformediastinalparathyroidadenomacausingprimaryhyperparathyroidism
AT ishibashikei surgicaltreatmentformediastinalparathyroidadenomacausingprimaryhyperparathyroidism
AT hayashisatoshi surgicaltreatmentformediastinalparathyroidadenomacausingprimaryhyperparathyroidism
AT okazakisatoru surgicaltreatmentformediastinalparathyroidadenomacausingprimaryhyperparathyroidism